Sunday, December 21, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Exane BNP Paribas Analyst Downgrades Expeditors International of Washington to Underperform

Elaine Mendonca by Elaine Mendonca
January 11, 2024
in Breaking News
0
Logistics Stock Market Today (2)
0
SHARES
7
VIEWS
Share on FacebookShare on Twitter

On January 11, 2024, Robert Joynson, an analyst at Exane BNP Paribas, made a distinctive move by downgrading Expeditors International of Washington (NYSE: EXPD) from Neutral to Underperform. Alongside this downgrade, Joynson set a price target of $116. The decision to downgrade was not taken lightly, as it was based on a comprehensive analysis that encompassed both quantitative and qualitative factors. Joynson carefully considered expected future growth, the current valuation of the stock, and macroeconomic trends. Consequently, the analyst believes that Expeditors International of Washington may face challenges and potentially underperform in the future.

[bs_slider_forecast ticker=”EXPD”]

EXPD Stock Analysis: Factors to Consider for Investment Decisions in 2024

On January 11, 2024, EXPD stock traded near the top of its 52-week range and above its 200-day simple moving average. The stock opened lower than its previous close, indicating a bearish sentiment at the start of the trading day. However, the slight price decrease of $0.09 may not necessarily indicate a significant change in the stock’s overall trajectory. Investors should consider various factors before making any investment decisions.

[stock_market_widget type=”chart” template=”basic” color=”#3946CE” assets=”EXPD” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” api=”yf”]

Expeditors International of Washington (EXPD) Stock Performance Analysis: January 11, 2024

EXPEDITORS INTERNATIONAL OF WASHINGTON (EXPD) STOCK PERFORMANCE ON JANUARY 11, 2024

Expeditors International of Washington (EXPD) is a global logistics company that provides freight forwarding and supply chain management services. As of January 11, 2024, the stock performance of EXPD can be analyzed based on the available information from CNN Money.

Total revenue for the past year was $17.07 billion, which represents a 3.32% increase compared to the previous year. However, in the third quarter of the same year, the total revenue remained flat at $2.19 billion.

Net income for the past year was $1.36 billion, reflecting a 4.1% decrease compared to the previous year. Similarly, in the third quarter of 2024, the net income further declined by 12.93% to $171.35 million.

Earnings per share (EPS) for the past year was $8.26, which remained flat compared to the previous year. However, in the third quarter of 2024, the EPS decreased by 10.84% to $1.16.

Investors may interpret these figures as a sign of concern, as the decrease in net income and EPS suggests a decline in profitability for EXPD. However, it is crucial to consider other factors such as market trends, industry competition, and the company’s overall financial stability before making any investment decisions.

It is important to note that stock performance is influenced by various factors, and a single day’s performance may not provide a complete picture of a company’s financial health. Investors should conduct thorough research and analysis, considering both short-term and long-term trends, before making any investment decisions.

Tags: EXPD
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Real Estate Investment Markets and money

W P Careys Strategic Sale of State of Andalusia Portfolio Positions Company for Growth

Biotechnology Markets and money

Emergent BioSolutions Safeguarding Public Health and National Security

Entertainment stock Trading

Redburn Atlantic Analyst Downgrades Paramount Global and Warner Bros Discovery

Recommended

JD.com Stock

Pivotal Week Ahead for JD.com as Major European Acquisition and EV Launch Converge

2 months ago
Snowflake Stock

Snowflake Faces Investor Confidence Test After Executive’s Rogue Forecast

2 months ago
Fiserv Stock

Fiserv’s Strategic Expansion Meets Legal Scrutiny

3 months ago
Does_Walmart_Take_Google_Pay

Does Walmart Take Google Pay? Exploring Walmart’s Exclusive Payment Solution

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin ASML BioNTech Bitcoin Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Intellia Therapeutics Faces Mounting Analyst Scrutiny Amid Regulatory Setback

Strategy Inc. Faces a Critical Index Classification Decision

DeFi Technologies Broadens Global Reach with New Listings and Products

Barrick Gold Secures Key Resolution in Mali, Paving Way for Mine Restart

Analyst Upgrade Sends Red Cat Shares Soaring

A Billion-Dollar Vote of Confidence for Standard Lithium

Trending

Tesla Stock
Automotive & E-Mobility

Tesla’s Valuation Faces Crucial Test Amid Legal Victory and Robotaxi Push

by Dieter Jaworski
December 21, 2025
0

Tesla shares are trading near their 52-week high as the company approaches a pivotal week, fueled by...

Wolfspeed Stock

Wolfspeed Secures Financial and Strategic Milestones

December 21, 2025
Textron Stock

Textron Stock Approaches Annual Peak Amid Strategic Wins

December 21, 2025
Intellia Therapeutics Stock

Intellia Therapeutics Faces Mounting Analyst Scrutiny Amid Regulatory Setback

December 21, 2025
Strategy Stock

Strategy Inc. Faces a Critical Index Classification Decision

December 21, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Tesla’s Valuation Faces Crucial Test Amid Legal Victory and Robotaxi Push
  • Wolfspeed Secures Financial and Strategic Milestones
  • Textron Stock Approaches Annual Peak Amid Strategic Wins

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com